Anticoagulación oral en la enfermedad renal crónica con fibrilación auricular
Resumen: La enfermedad renal crónica (ERC) y la fibrilación auricular (FA) frecuentemente coexisten, amplificando el riesgo de eventos cardiovasculares y de mortalidad. En pacientes con ERC estadio 3 y FA no valvular los anticoagulantes orales de acción directa (ACOD) han demostrado, comparados con...
Main Authors: | Pablo Gómez-Fernández, Antonio Martín Santana, Juan de Dios Arjona Barrionuevo |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Elsevier
2021-03-01
|
Series: | Nefrología |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0211699520301624 |
Similar Items
-
Non-valvular Atrial Fibrillation in CKD: Role of Vitamin K Antagonists and Direct Oral Anticoagulants. A Narrative Review
by: Aleix Cases, et al.
Published: (2021-09-01) -
Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Iwona Gorczyca, et al.
Published: (2020-11-01) -
2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
by: Chern-En Chiang, MD, PhD, et al.
Published: (2017-08-01) -
2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
by: Chern-En Chiang, et al.
Published: (2016-11-01) -
Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
by: Song T, et al.
Published: (2021-03-01)